Organogenesis Holdings Inc. (ORGO)

NASDAQ: ORGO · USD

$0.82

-0.08 (-8.8%)· Recorded snapshot

Market cap	105.9M
Revenue (ttm)	457.5M
Net income (ttm)	-101.7M
EPS (ttm)	-$0.80
Shares out	128.7M
Volume	1,685,299
Beta	1.27

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 457.5M
Net income (ttm): -101.7M
EPS (ttm): -$0.80
Market cap: 105.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	احتفاظ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-25.9

P25 n/aP50 n/aP75 n/a

ROIC-8.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ORGO indicators

Market & fundamental data

Available fields

223

Groups with data

Currency

USD

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001661181
Company name	Organogenesis Holdings Inc.
Country	United States
Country code	US
CUSIP number	68621F102
Earnings date	2026-11-05
Earnings time	amc
Employees	854
Employees change	-15
Employees growth	-1.73%
Enterprise value	$126.7M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1985
In index	RUSSELL2000
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
Is SPAC	No
ISIN number	US68621F1021
Last 10-K release date	2026-02-26
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$105.9M
Market cap category	Micro-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$0.82
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ORGO
U.S. state	Massachusetts
Website	https://organogenesis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-97.32%
EV/FCF	6.14x
EV/Sales	0.28x
FCF / EV yield	16.28%
FCF yield	19.45%
Forward EV/Sales	0.58x
Forward P/S	0.49x
Industry forward P/E	13.59x
Industry P/E	175.96x
P/(FCF - SBC) ratio	15.84x
P/(OCF - SBC) ratio	5.99x
P/B ratio	0.78x
P/FCF ratio	5.14x
P/OCF ratio	3.35x
P/S ratio	0.23x
Price / tangible book value	0.92x
Sector forward P/E	23.53x
Sector P/E	51.01x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-6.23%
EBITDA margin	-2.12%
FCF margin	4.56%
Gross margin	71.49%
Operating margin	-6.23%
Pretax margin	-7.6%
Profit margin	-18.4%
Profit per employee	$-119,067
Profitable years	1
Revenue per employee	$535,660
ROA	-4.11%
ROA (5Y)	5.59%
ROCE	-8.15%
ROE	-25.92%
ROE (5Y)	13.28%
ROIC	-8.51%
ROIC (5Y)	13.27%
SBC / revenue	3.08%
Tax / revenue	10.8%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
FCF growth 5Y	-5.54%
Gross profit growth	2.09%
Gross profit growth (Q)	-72.63%
Gross profit growth 3Y	-2.34%
Gross profit growth 5Y	-0.15%
Net income growth years	1
OCF growth 3Y	23.87%
OCF growth 5Y	-7.91%
Revenue growth	6.5%
Revenue growth (Q)	-56.68%
Revenue growth (QoQ)	17.53%
Revenue growth 10Y	50.99%
Revenue growth 3Y	0.01%
Revenue growth 5Y	1.09%
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-11.1M
Depreciation and amortization	$18.8M
EBIT	$-28.5M
EBITDA	$-9.7M
EPS	$-0.80
FCF per share	$0.16
Financing cash flow	$-47.7M
Free cash flow	$20.8M
Free cash flow minus SBC	$6.8M
Gross profit	$327M
Income taxes	$49.4M
Investing cash flow	$-11.1M
Net borrowing	$-10.8M
Net cash flow	$-26.9M
Net income	$-101.7M
Operating cash flow minus SBC	$17.9M
Operating income	$-28.5M
Revenue	$457.5M
Stock-based compensation	$14.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.29
Book value per share	$1.15
Debt / EBITDA	4.93
Debt / equity	0.23
Debt / FCF	3.21
Goodwill	$28.8M
Long-term assets	$206.1M
Long-term liabilities	$61.4M
Net cash (debt)	$-20.9M
Net cash / market cap	-19.46%
Net debt / equity	0.07
Net debt / FCF	1
Piotroski F-Score	3
Property, plant and equipment	$151.4M
Shareholders' equity	$288.1M
Tangible book value	$116.5M
Tangible book value per share	$0.91
Total assets	$406.4M
Total cash	$46.1M
Total debt	$67M
Total liabilities	$118.3M
WACC	6.91%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.05
Current assets	$200.3M
Current liabilities	$57M
Current ratio	3.52
Inventory turnover	4.19
Net working capital	$106.6M
Quick ratio	2.58
Working capital	$143.3M
Working capital turnover	2.71

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1%
Dividend yield	0%
Shareholder yield	1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$2.06
1D price change	-8.81%
1M price change	-41.64%
1M total return	-41.64%
1W price change	-16.99%
1W total return	-16.99%
1Y price change	-80.77%
1Y return CAGR	-80.8%
1Y total return	-80.77%
20-day SMA	$1.13
200-day SMA	$2.40
3M price change	-67.73%
3M total return	-67.73%
3Y price change	-61.73%
3Y return CAGR	-27.39%
3Y total return	-61.73%
50-day SMA	$1.40
50-day SMA vs 200-day SMA	50under200
52-week high	$7.08
52-week high date	2025-11-11
52-week low	$0.81
52-week low date	2026-10-28
5Y price change	-92.28%
5Y return CAGR	-40.09%
5Y total return	-92.28%
6M price change	-65.57%
6M total return	-65.57%
All-time high	$310.90
All-time high date	2019-01-09
All-time low	$0.81
All-time low date	2026-10-28
Average true range (ATR)	$0.08
Average volume	942.1K
Beta (1Y)	0.3
Beta (2Y)	1.39
Beta (5Y)	1.27
Change from 52-week high	-88.37%
Change from 52-week low	1.52%
Change from all-time high	-99.74%
Change from all-time low	1.55%
Change from open	-7.64%
Day's gap	-1.26%
Dollar volume	$1.4M
High price	$0.92
Low price	$0.81
Monthly RSI	35.17
Open price	$0.89
Position in 52-week range	11.75%
Premarket change	0%
Premarket close	$0.90
Premarket price	$0.90
Previous close	$0.90
Price vs 150-day SMA	-60.07%
Price vs 20-day SMA	-27.37%
Price vs 200-day SMA	-65.77%
Price vs 50-day SMA	-41.1%
Relative volume	1.83
RSI	18.19
Sharpe ratio	-1.78
Sharpe ratio (3Y)	0.06
Sharpe ratio (5Y)	-0.21
Sortino ratio	-2.62
Sortino ratio (3Y)	0.19
Sortino ratio (5Y)	-0.28
Volume	1.7M
Weekly RSI	20.29
YTD price change	-84.11%
YTD total return	-84.11%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	61.1M
Float percentage	47.45%
Shares change (QoQ)	0.69%
Shares change (YoY)	-1%
Shares held by insiders	36.02%
Shares held by institutions	43.87%
Shares outstanding	128.7M
Short % of float	24.57%
Short % of shares	11.66%
Short ratio	22.8 days

Deeper analysis on ORGO

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ORGO report

Is a complete ORGO research report available?

No complete published report is available for Organogenesis Holdings Inc. (ORGO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Organogenesis Holdings Inc. (ORGO)

Price

Financial snapshot

Fair-value bridge

Latest news · ORGO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ORGO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ORGO

Frequently asked questions